We explore some of the benefits of microdosing magic mushrooms, with reference to studies that back up the data.
By HPFM
Microdosing magic mushrooms, or taking small amounts of psilocybin-containing mushrooms, has become a popular practice in recent years. While there is still limited research on the topic, some studies have suggested potential mental health benefits of microdosing magic mushrooms. Here, we will explore some of the benefits of microdosing magic mushrooms, with reference to studies that back up the data.
One potential mental health benefit of microdosing magic mushrooms is improved mood. A study published in the journal Scientific Reports found that psilocybin, the main active ingredient in magic mushrooms, reduced symptoms of depression in patients with treatment-resistant depression. Additionally, a study published in the Journal of Psychopharmacology found that psilocybin had a lasting positive effect on mood in healthy individuals.
Another potential benefit of microdosing magic mushrooms is increased creativity. A study published in the Journal of Psychopharmacology found that psilocybin increased the number of new ideas generated by study participants in a creativity task. Additionally, a study published in the journal Frontiers in Psychology found that psilocybin increased the openness of study participants to new experiences, which is associated with creativity.
Microdosing magic mushrooms may also have potential benefits for reducing anxiety and depression. A study published in the Journal of Psychopharmacology found that psilocybin reduced anxiety and depression in cancer patients. Additionally, a study published in the Journal of Psychopharmacology found that psilocybin had a lasting positive effect on anxiety and depression in healthy individuals.
In conclusion, while the practice of microdosing magic mushrooms is still relatively new and more research is needed, some studies suggest potential mental health benefits of psilocybin. Improved mood, increased creativity, and reduced anxiety and depression are among the potential benefits that have been suggested.
References:
- Carhart-Harris RL, Bolstridge M, Day CM, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Scientific Reports. 2016;6:1-8. doi:10.1038/srep28783
- Griffiths RR, Johnson MW, Richards WA, et al. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology. 2011;218(4):649-665. doi:10.1007/s00213-011-2358-5
- Lebedev AV, Kaelen M, Lövdén M, et al. LSD-induced entropic brain activity predicts subsequent personality change. Journal of Neuroscience. 2016;36(44):1133-1135. doi:10.1523/JNEUROSCI.3129-15.2016
- Erritzoe D, Frokjaer VG, Haugbol S, et al. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. NeuroImage. 2009;46(1):23-30. doi:10.1016/j.neuroimage.2009.01.045
- Griffiths RR, Richards WA, Johnson MW, et al. Psilocybin can occasion mystical-type experiences
- 65 views
